FibroBiologics, Inc. - FBLG

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$301K
QoQ value delta ($000)
+$35K (+13.16%)
Implied price effect (QoQ)
+3.42%
Shares
Total shares
311,818
QoQ shares delta
+26,831 (+9.41%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (FBLG)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Cascade Financial Partners, LLC 103 108,828 0.01%
Fund Evaluation Group, LLC 49 51,794 0.0%
IFP Advisors, Inc 35 27,000 0.0%
GEODE CAPITAL MANAGEMENT, LLC 28 30,299 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 26 27,769 0.0%
Qube Research & Technologies Ltd 23 24,313 0.0%
BlackRock, Inc. 17 18,238 0.0%
BARCLAYS PLC 6 7,243 0.0%
VANGUARD FIDUCIARY TRUST CO 6 6,380 0.0%
Tower Research Capital LLC (TRC) 4 4,728 0.0%
OSAIC HOLDINGS, INC. 2 2,404 0.0%
ROYAL BANK OF CANADA 1 1,522 0.0%
UBS Group AG 1 1,073 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 64 0.0%
Allworth Financial LP 0 13 0.0%
Grove Bank & Trust 0 100 0.0%
BFC Planning, Inc. 0 50 0.0%